Precision NanoSystems On 2015 Ready to Rocket List

Press Release

February 27, 2015

Vancouver, BC, Canada

Precision NanoSystems Inc. (PNI) has been selected into Rocket Builder’s list of life science companies that is poised to capitalize on growth opportunities. The Ready to Rocket selection provides PNI with the platform to extend its reach into the nanotechnology and life science communities while continuing to build partnerships. James Taylor, PhD, CEO of Precision NanoSystems comments, “It is a great achievement to be recognized for our efforts amongst such a prestigious group of companies. Rocket Builders has proven its ability in the past to find game-changing technology companies, and so we take our inclusion on this list as a great vote of confidence in what we are doing.”

“We identify companies that have both innovative technology and a fit within the industry value chain. Our analysis of the market and the company progress led to our selection of Precision NanoSystems Inc. as a Ready to Rocket Life Sciences company.” said Thealzel Lee, Senior Partner, Rocket Builders.

About Precision NanoSystems, Inc.

Precision NanoSystems, Inc. (PNI) has developed innovative tools and processes for the development and manufacture of best-in-class nanoparticles for use as medicines, and in medical research. PNI’s proprietary NanoAssemblr™ platform enables the simple, rapid, reproducible, and scalable manufacture of next-generation nanoparticle formulations for the targeted delivery of therapeutic and diagnostic agents to difficult-to-access cells and tissues in the body. PNI provides instruments, reagents and services to life sciences researchers and builds strategic collaborations to revolutionize healthcare through nanotechnology. For more information, visit our website.

About Ready to Rocket

Ready to Rocket is a unique business recognition list that profiles technology companies with the greatest potential for growth. Each year, based on analysis of trends, Rocket Builders identifies the top private companies that are best positioned to capitalize on these trends to achieve growth. This selection methodology has been an accurate predictor of investment and business success with past “Ready to Rocket” companies.


Press Release

Precision NanoSystems, Inc. (PNI), a privately held biotechnology company developing proprietary microfluidic-based manufacturing technology for the use and development of cutting edge nanomedicines, today announced completion of its initial extern...

Read More

News Article

The NIH and Moderna have begun phase 1 clinical trials for a vaccine to protect against COVID-19. The vaccine, called mRNA-1273, is an advanced mRNA vaccine that utilizes genetic material to immunize patients. Moderna and the NIH were able to bring mRNA-1273 to clinical trials wi...
Read More